Louis C. Bock, Director, 10% Owner at Orexigen Therapeutics, Inc. (OREX), sold 16,142 shares at $15.58 ($251K) on 2007-11-16, disclosed to the SEC on 2007-11-19.
Open-market sale of $251k OREX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.41 | 100 | $2K | 0.6% |
| 2 | $15.45 | 500 | $8K | 3.1% |
| 3 | $15.45 | 1,046 | $16K | 6.4% |
| 4 | $15.46 | 200 | $3K | 1.2% |
| 5 | $15.47 | 100 | $2K | 0.6% |
| 6 | $15.48 | 100 |
| $2K |
| 0.6% |
| 7 | $15.50 | 1,800 | $28K | 11.1% |
| 8 | $15.51 | 300 | $5K | 1.9% |
| 9 | $15.52 | 200 | $3K | 1.2% |
| 10 | $15.53 | 1,300 | $20K | 8.1% |
| 11 | $15.54 | 700 | $11K | 4.3% |
| 12 | $15.55 | 1,300 | $20K | 8.1% |
| 13 | $15.55 | 6,300 | $98K | 39.1% |
| 14 | $15.56 | 600 | $9K | 3.7% |
| 15 | $15.57 | 796 | $12K | 4.9% |
| 16 | $15.58 | 800 | $12K | 5.0% |
| Total | $15.53 avg | 16,142 | $251K | 100% |
| Filing → |
| OREX | BUY | 2014-11-13 | $151K | — | Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |